Small cell carcinoma of the cervix: A clinical and flow-cytometric study

B. Miller, M. Dockter, M. El Torky, G. Photopulos

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

The clinical course of 14 patients diagnosed with small cell carcinoma of the cervix (SCC) was reviewed and compared to that of 37 cases of undifferentiated large cell nonkeratonizing carcinoma (LCNK). We observed the following differences between the two: SCC patients had a higher incidence of pelvic wall involvement and distant metastasis; the development of progressive disease was more frequent in SCC than in LCNK patients; median survival time was 9 months in SCC and 40 months in LCNK patients; flow cytometry revealed aneuploidy in all SCC and in 30% of the LCNK patients; the mean DNA index was 2.24 in SCC, significantly higher than in LCNK (1.15). DNA index in cases of SCC was related to survival time. SCC of the cervix is an extremely aggressive tumor, even when compared to other undifferentiated cervical cancers. Aneuploidy is a consistent feature and thus helpful for diagnosis. Due to the wide range of values, the DNA index cannot be used for diagnostic purposes, but it is of prognostic importance in SCC cases.

Original languageEnglish (US)
Pages (from-to)27-33
Number of pages7
JournalGynecologic Oncology
Volume42
Issue number1
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Small Cell Carcinoma
Cervix Uteri
Large Cell Carcinoma
Aneuploidy
DNA
Survival
Uterine Cervical Neoplasms
Flow Cytometry
Neoplasm Metastasis

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Small cell carcinoma of the cervix : A clinical and flow-cytometric study. / Miller, B.; Dockter, M.; El Torky, M.; Photopulos, G.

In: Gynecologic Oncology, Vol. 42, No. 1, 1991, p. 27-33.

Research output: Contribution to journalArticle

Miller, B. ; Dockter, M. ; El Torky, M. ; Photopulos, G. / Small cell carcinoma of the cervix : A clinical and flow-cytometric study. In: Gynecologic Oncology. 1991 ; Vol. 42, No. 1. pp. 27-33.
@article{e2fbaa5f535640a8be91368087c5d676,
title = "Small cell carcinoma of the cervix: A clinical and flow-cytometric study",
abstract = "The clinical course of 14 patients diagnosed with small cell carcinoma of the cervix (SCC) was reviewed and compared to that of 37 cases of undifferentiated large cell nonkeratonizing carcinoma (LCNK). We observed the following differences between the two: SCC patients had a higher incidence of pelvic wall involvement and distant metastasis; the development of progressive disease was more frequent in SCC than in LCNK patients; median survival time was 9 months in SCC and 40 months in LCNK patients; flow cytometry revealed aneuploidy in all SCC and in 30{\%} of the LCNK patients; the mean DNA index was 2.24 in SCC, significantly higher than in LCNK (1.15). DNA index in cases of SCC was related to survival time. SCC of the cervix is an extremely aggressive tumor, even when compared to other undifferentiated cervical cancers. Aneuploidy is a consistent feature and thus helpful for diagnosis. Due to the wide range of values, the DNA index cannot be used for diagnostic purposes, but it is of prognostic importance in SCC cases.",
author = "B. Miller and M. Dockter and {El Torky}, M. and G. Photopulos",
year = "1991",
doi = "10.1016/0090-8258(91)90225-T",
language = "English (US)",
volume = "42",
pages = "27--33",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Small cell carcinoma of the cervix

T2 - A clinical and flow-cytometric study

AU - Miller, B.

AU - Dockter, M.

AU - El Torky, M.

AU - Photopulos, G.

PY - 1991

Y1 - 1991

N2 - The clinical course of 14 patients diagnosed with small cell carcinoma of the cervix (SCC) was reviewed and compared to that of 37 cases of undifferentiated large cell nonkeratonizing carcinoma (LCNK). We observed the following differences between the two: SCC patients had a higher incidence of pelvic wall involvement and distant metastasis; the development of progressive disease was more frequent in SCC than in LCNK patients; median survival time was 9 months in SCC and 40 months in LCNK patients; flow cytometry revealed aneuploidy in all SCC and in 30% of the LCNK patients; the mean DNA index was 2.24 in SCC, significantly higher than in LCNK (1.15). DNA index in cases of SCC was related to survival time. SCC of the cervix is an extremely aggressive tumor, even when compared to other undifferentiated cervical cancers. Aneuploidy is a consistent feature and thus helpful for diagnosis. Due to the wide range of values, the DNA index cannot be used for diagnostic purposes, but it is of prognostic importance in SCC cases.

AB - The clinical course of 14 patients diagnosed with small cell carcinoma of the cervix (SCC) was reviewed and compared to that of 37 cases of undifferentiated large cell nonkeratonizing carcinoma (LCNK). We observed the following differences between the two: SCC patients had a higher incidence of pelvic wall involvement and distant metastasis; the development of progressive disease was more frequent in SCC than in LCNK patients; median survival time was 9 months in SCC and 40 months in LCNK patients; flow cytometry revealed aneuploidy in all SCC and in 30% of the LCNK patients; the mean DNA index was 2.24 in SCC, significantly higher than in LCNK (1.15). DNA index in cases of SCC was related to survival time. SCC of the cervix is an extremely aggressive tumor, even when compared to other undifferentiated cervical cancers. Aneuploidy is a consistent feature and thus helpful for diagnosis. Due to the wide range of values, the DNA index cannot be used for diagnostic purposes, but it is of prognostic importance in SCC cases.

UR - http://www.scopus.com/inward/record.url?scp=0026062973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026062973&partnerID=8YFLogxK

U2 - 10.1016/0090-8258(91)90225-T

DO - 10.1016/0090-8258(91)90225-T

M3 - Article

C2 - 1655594

AN - SCOPUS:0026062973

VL - 42

SP - 27

EP - 33

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 1

ER -